#Innate Pharma
articles
Companies
Innate Pharma's Overnight €30m Capital Raise Sends Shares Down 18%
The French biotech priced a €30m equity raise at €1.70 per share, a 15% discount, to fund its IPH4502 ADC programme; inv...
Companies
Innate Pharma Stock Jumps Over 15% on No Apparent News as Volume Explodes
Shares of French immuno-oncology biotech Innate Pharma surged by more than 15% on Monday, accompanied by a massive spike...